(Q36354709)

13 August 2017

1 reference

title

NKG2D in NK and T cell-mediated immunity (English)

1 reference

13 August 2017

Kouetsu Ogasawara

1

1 reference

PubMed ID

16380817

13 August 2017

Lewis L Lanier

series ordinal

2

1 reference

13 August 2017

1 November 2005

1 reference

Journal of Clinical Immunology

13 August 2017

1 reference

13 August 2017

25

1 reference

13 August 2017

534-540

1 reference

13 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-005-8786-4

13 August 2017

0 references

cites work

A Structural basis for the association of DAP12 with mouse, but not human, NKG2D

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Effect of human cytomegalovirus on expression of MHC class I-related chains A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

IL-21 enhances tumor rejection through a NKG2D-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Requirements of NK cells and proinflammatory cytokines in T cell-dependent neonatal autoimmune ovarian disease triggered by immune complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-005-8786-4

Natural killer cells determine the outcome of B cell–mediated autoimmunity

21 January 2018

1 reference

12 December 2020

NKG2D blockade prevents autoimmune diabetes in NOD mice

1 reference

12 December 2020

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

1 reference

12 December 2020

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

1 reference

12 December 2020

A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3

1 reference

12 December 2020

Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice

1 reference

12 December 2020

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

1 reference

12 December 2020

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized

1 reference

12 December 2020

Impairment of NK cell function by NKG2D modulation in NOD mice.

1 reference

12 December 2020

Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum

1 reference

12 December 2020

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

12 December 2020

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

12 December 2020

Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts

1 reference

12 December 2020

NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer

1 reference

12 December 2020

Induction of Immunity and of Unresponsiveness to Parental Marrow Grafts in Adult F1 Hybrid Mice

1 reference

12 December 2020

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

1 reference

12 December 2020

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

1 reference

12 December 2020

NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules

1 reference

12 December 2020

Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties

1 reference

12 December 2020

Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts

1 reference

12 December 2020

The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.

1 reference

12 December 2020

Roles of the NKG2D immunoreceptor and its ligands

1 reference

12 December 2020

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity

1 reference

12 December 2020

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

1 reference

12 December 2020

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

1 reference

12 December 2020

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity

1 reference

12 December 2020

DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells

1 reference

12 December 2020

Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

1 reference

12 December 2020

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

1 reference

12 December 2020

Murine natural killer cells and marrow graft rejection

1 reference

12 December 2020

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

1 reference

12 December 2020

NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.

1 reference

12 December 2020

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity

1 reference

12 December 2020

The molecular and functional characterization of a dominant minor H antigen, H60.

1 reference

12 December 2020

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

12 December 2020

MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function

1 reference

12 December 2020

Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.

1 reference

12 December 2020

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

1 reference

12 December 2020

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

1 reference

12 December 2020

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

12 December 2020

ULBP4 is a novel ligand for human NKG2D

1 reference

12 December 2020

Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f

1 reference

12 December 2020

Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus

1 reference

12 December 2020

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

12 December 2020

1 reference

12 December 2020

The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions

1 reference

12 December 2020

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

1 reference

12 December 2020

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

12 December 2020

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

12 December 2020

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

12 December 2020

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

12 December 2020

Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L.

1 reference

12 December 2020

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

12 December 2020

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

1 reference

12 December 2020

MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.

1 reference

12 December 2020

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

12 December 2020

Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages

1 reference

12 December 2020

The NOD mouse: a model of immune dysregulation

1 reference

12 December 2020

NKG2D function protects the host from tumor initiation

1 reference

12 December 2020

10.1007/S10875-005-8786-4

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16380817